ROBERT S. GALEN, M.D., M.P.H.
To the editor: Korvin, Pearce, and Stanley conclude their paper in the August issue, "Admissions Screening: Clinical Benefits" by stating that "despite the significant number of abnormal laboratory results encountered in an admissions screening program, these have little beneficial impact on patient care" (1). The biggest problem with their study is that the application of a panel of tests, laboratory or other, to patients upon admission to hospital is not "screening." The World Health Assembly in 1971 recognized the existing confusion in terminology and set forth the following definition of screening for disease, the aim of which is to discover
GALEN RS. Evaluation, Profiling, and Screening. Ann Intern Med. ;83:905–907. doi: 10.7326/0003-4819-83-6-905_2
Download citation file:
Published: Ann Intern Med. 1975;83(6):905-907.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use